Standard BioTools(LAB) - 2020 Q4 - Earnings Call Presentation

Investor Presentation Q4 2020 February 10, 2021 Legal Information Forward-looking statements This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including, among others, statements regarding revenue growth and opportunities, development and expansion of Fluidigm's diagnostic business, new product releases, additional collaborations and partnerships, benefits and increasing adoption and utilization of Fluidigm mass cytometry produc ...